{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:03:14Z","timestamp":1765040594131,"version":"3.44.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.brainres.2015.12.036","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T02:00:28Z","timestamp":1451354428000},"page":"115-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"1633","author":[{"given":"Candace H.","family":"Carriere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na Hyea","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennard P.","family":"Niles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2015.12.036_bib1","first-page":"PL23","article-title":"Melatonin is protective against MPTP-induced striatal and hippocampal lesions","volume":"60","author":"Acuna-Castroviejo","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2015.12.036_bib2","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal melatonin: sources, regulation, and potential functions","volume":"71","author":"Acu\u00f1a-Castroviejo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.brainres.2015.12.036_bib3","first-page":"BR61","article-title":"Melatonin MT1 and MT2 receptor expression in Parkinson\u05f3s disease","volume":"16","author":"Adi","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.brainres.2015.12.036_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2008.08.014","article-title":"Exogenous melatonin decreases age-induced lipid peroxidation in the brain","volume":"1238","author":"Akbulut","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00001756-200203250-00023","article-title":"Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells","volume":"13","author":"Armstrong","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2015.12.036_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","article-title":"Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u05f3s disease model in rats","volume":"1593","author":"Bassani","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.neuroscience.2005.05.048","article-title":"Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels","volume":"135","author":"Baydas","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.12.036_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00441-004-0976-5","article-title":"Redox imbalance","volume":"318","author":"Berg","year":"2004","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u05f3s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2015.12.036_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-079X.2009.00713.x","article-title":"Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents","volume":"47","author":"Borah","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u05f3s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2015.12.036_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2014.02.028","article-title":"Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson\u05f3s disease","volume":"267C","author":"Carriere","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.12.036_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.brainres.2015.12.036_bib15","first-page":"1","article-title":"GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson\u05f3s disease","volume":"9","author":"d\u05f3Anglemont de Tassigny","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.brainres.2015.12.036_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbr.2008.01.012","article-title":"Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission","volume":"189","author":"Da Cunha","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1096\/fj.00-0129com","article-title":"Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity","volume":"15","author":"Dabbeni-Sala","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2015.12.036_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbr.2010.06.028","article-title":"Microdialysis study of striatal dopamine in MPTP-hemilesioned rats challenged with apomorphine and amphetamine","volume":"215","author":"Dombrowski","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157015910792246155","article-title":"Antiinflammatory activity of melatonin in central nervous system","volume":"8","author":"Esposito","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainres.2015.12.036_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-079X.2008.00633.x","article-title":"Melatonin reduces stress-activated\/mitogen-activated protein kinases in spinal cord injury","volume":"46","author":"Esposito","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2014.12.017","article-title":"Epigenetic mechanisms in Parkinson\u05f3s disease","volume":"349","author":"Feng","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2015.12.036_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2011.00916.x","article-title":"Melatonin as a natural ally against oxidative stress: a physicochemical examination","volume":"51","author":"Galano","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0149-7634(95)00052-6","article-title":"Melatonin effects on behavior: possible mediation by the central GABAergic system","volume":"20","author":"Golombek","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2015.12.036_bib24","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1460-9568.2010.07265.x","article-title":"Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson\u05f3s disease","volume":"31","author":"Grealish","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2015.12.036_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2010.12.004","article-title":"Melatonin-A pleiotropic, orchestrating regulator molecule","author":"Hardeland","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2015.12.036_bib26","doi-asserted-by":"crossref","DOI":"10.2174\/187152412802430129","article-title":"Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system","author":"Hardeland","year":"2012","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.brainres.2015.12.036_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson\u05f3s disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2015.12.036_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u05f3s disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12576-008-0003-9","article-title":"Gene structures, biochemical characterization and distribution of rat melatonin receptors","volume":"59","author":"Ishii","year":"2009","journal-title":"J. Physiol. Sci."},{"issue":"Suppl 3","key":"10.1016\/j.brainres.2015.12.036_bib30","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u05f3s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2015.12.036_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8619(18)30217-2","article-title":"What process causes nigral cell death in Parkinson\u05f3s disease?","volume":"10","author":"Jenner","year":"1992","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.brainres.2015.12.036_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-079X.2004.00178.x","article-title":"Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice","volume":"38","author":"Kilic","year":"2005","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2015.12.036_bib34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1292\/jvms.70.1219","article-title":"Melatonin attenuates the cerebral ischemic injury via the MEK\/ERK\/p90RSK\/Bad signaling cascade","volume":"70","author":"Koh","year":"2008","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.brainres.2015.12.036_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","article-title":"Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders","volume":"66","author":"Konsoula","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.brainres.2015.12.036_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u05f3s disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2015.12.036_bib38","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1096\/fj.10-154450","article-title":"Melatonin signaling and cell protection function","volume":"24","author":"Luchetti","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2015.12.036_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","article-title":"Does melatonin help save dopaminergic cells in MPTP-treated mice?","volume":"15","author":"Ma","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.brainres.2015.12.036_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yfrne.2004.08.001","article-title":"Human pineal physiology and functional significance of melatonin","volume":"25","author":"Macchi","year":"2004","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.brainres.2015.12.036_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1034\/j.1600-079X.2000.280407.x","article-title":"Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo","volume":"28","author":"Mart\u00edn","year":"2000","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1357-2725(01)00138-8","article-title":"Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria","volume":"34","author":"Mart\u00edn","year":"2002","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"Pt 1","key":"10.1016\/j.brainres.2015.12.036_bib43","first-page":"1","article-title":"If you assume, you can make an ass out of u and me\u05f3: a decade of the disector for stereological counting of particles in 3D space","volume":"188","author":"Mayhew","year":"1996","journal-title":"J. Anat."},{"key":"10.1016\/j.brainres.2015.12.036_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1385\/ENDO:27:2:169","article-title":"Melatonin and Parkinson\u05f3s disease","volume":"27","author":"Mayo","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.brainres.2015.12.036_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2007.04.029","article-title":"Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells","volume":"419","author":"McMillan","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2015.12.036_bib46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","article-title":"Valproic acid is neuroprotective in the rotenone rat model of Parkinson\u05f3s disease: involvement of alpha-synuclein","volume":"17","author":"Monti","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2011.01.038","article-title":"Characterisation of a novel model of Parkinson\u05f3s disease by intra-striatal infusion of the pesticide rotenone","volume":"181","author":"Mulcahy","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2015.12.036_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2013.01.050","article-title":"Melatonin induces histone hyperacetylation in the rat brain","volume":"541","author":"Niles","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2015.12.036_bib49","first-page":"1","article-title":"Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells","author":"Pan","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.brainres.2015.12.036_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","article-title":"Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways","volume":"85","author":"Pandi-Perumal","year":"2008","journal-title":"Prog. Neurobiol."},{"year":"2007","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.brainres.2015.12.036_bib51"},{"key":"10.1016\/j.brainres.2015.12.036_bib52","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/endo.140.2.6674","article-title":"Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels","volume":"140","author":"Rasmussen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2015.12.036_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2478\/v10102-010-0030-2","article-title":"Melatonin combats molecular terrorism at the mitochondrial level","volume":"1","author":"Reiter","year":"2008","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.brainres.2015.12.036_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1196\/annals.1332.012","article-title":"Melatonin relieves the neural oxidative burden that contributes to dementias","volume":"1035","author":"Reiter","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2015.12.036_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson\u05f3s disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-079X.2008.00587.x","article-title":"Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells","volume":"45","author":"Sharma","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4914(03)00117-5","article-title":"Disease model: Parkinson\u05f3s disease","volume":"9","author":"Shimohama","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.brainres.2015.12.036_bib59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2015.12.036_bib60","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.drudis.2014.04.014","article-title":"Melatonin: functions and ligands","volume":"19","author":"Singh","year":"2014","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.brainres.2015.12.036_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-011-8225-x","article-title":"Melatonin as a neuroprotective agent in the rodent models of Parkinson\u05f3s disease: is it all set to irrefutable clinical translation?","volume":"45","author":"Singhal","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2015.12.036_bib62","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/endo.140.10.7074","article-title":"High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus","volume":"140","author":"Skinner","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2015.12.036_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1756285611406166","article-title":"Therapeutic potential of melatonin and its analogs in Parkinson\u05f3s disease: focus on sleep and neuroprotection","volume":"4","author":"Srinivasan","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.brainres.2015.12.036_bib64","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3727\/096368913X667510","article-title":"Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia","volume":"23","author":"Tang","year":"2014","journal-title":"Cell. Transpl."},{"key":"10.1016\/j.brainres.2015.12.036_bib65","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<593::AID-JNR9>3.0.CO;2-4","article-title":"Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments","volume":"53","author":"Tang","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib66","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1002\/jnr.22123","article-title":"Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice","volume":"87","author":"Tapias","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib67","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u05f3s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2015.12.036_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0303-7207(93)90234-B","article-title":"Physiological regulation of melatonin receptors in rat suprachiasmatic nuclei: diurnal rhythmicity and effects of stress","volume":"98","author":"Tenn","year":"1993","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.brainres.2015.12.036_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-079X.2003.00096.x","article-title":"Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum","volume":"36","author":"Thomas","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbrainres.2005.01.002","article-title":"The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system","volume":"136","author":"Uz","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1600-079x.2002.10813.x","article-title":"Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus","volume":"32","author":"Venero","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","article-title":"Genes, proteins, and neurotoxins involved in Parkinson\u05f3s disease","volume":"73","author":"Von Bohlen und Halbach","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2015.12.036_bib73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00441-002-0581-4","article-title":"Mammalian melatonin receptors: molecular biology and signal transduction","volume":"309","author":"Von Gall","year":"2002","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.brainres.2015.12.036_bib74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mce.2014.12.013","article-title":"The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome","volume":"401","author":"Vriend","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.brainres.2015.12.036_bib75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.pharmtox.40.1.353","article-title":"Mitochondrial targets of drug toxicity","volume":"40","author":"Wallace","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.brainres.2015.12.036_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2015.12.036_bib77","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.expneurol.2008.02.024","article-title":"Enhanced function in the good forelimb of hemi-parkinson rats: compensatory adaptation for contralateral postural instability?","volume":"211","author":"Woodlee","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2015.12.036_bib78","first-page":"4072","article-title":"Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson\u05f3s disease","volume":"125","author":"Wu","year":"2012","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.brainres.2015.12.036_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1461145705005547","article-title":"Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats","volume":"9","author":"Yang","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899315009750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899315009750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:55:59Z","timestamp":1757786159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899315009750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":79,"alternative-id":["S0006899315009750"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2015.12.036","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2015.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}